✦ LIBER ✦

Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (IGHy) in a Subset of Study Patients With Primary Immunodeficiency Disease (PIDD)

✍ Scribed by Wasserman, R.L.; Melamed, I.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H.; Gelmont, D.; Schiff, R.I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Pharmacokinetics of Facilitat

✍ Melamed, I.; Wasserman, R.L.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Stein, M.; Wasserman, R.L.; Melamed, I.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Tolerability of Human Immunoglobulin 10%

✍ Gelmont, D.; Wasserman, R.L.; Melamed, I.; Stein, M.; Rubinstein, A.; McCoy, B.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Efficacy Analysis of Immune Globulin Sub

✍ Schiff, R.I.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Gelm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Pharmacokinetics and safety of subcutane

✍ R. L. Wasserman; A.-M. Irani; J. Tracy; C. Tsoukas; D. Stark; R. Levy; J. Chen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

Efficacy, Safety and Tolerability of a N

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB